Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrobulbar Triamcinolone Acetonide for NAION
NCT02329288Phase 3Unknown
- Sponsor
- Naval Medical University
- Start
- May 2015
- Primary completion
- Dec 2015
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of triamcinolone acetonide in non-arteritic anterior ischemic optic neuropathy (NAION), sponsored by Naval Medical University. Status: unknown.
02
Drugs
triamcinolone acetonide
03
Conditions
non-arteritic anterior ischemic optic neuropathy (NAION)
Beyond the preview
Go deeper on NCT02329288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02329288.